Attempting to alleviate pain with a manufacturer recommended surgical device should not cause more harm than the original pain. These companies have one job; alleviate the pain. They should not cause more suffering. Individuals who went under the knife to receive a hernia mesh implant are now realizing this was a grave mistake. Doctor’s were informed hernia mesh was the top tier medical device treatment to help patients suffering from any type of hernia. This could not be further from the truth.
Read MoreZantac Pulled From Store Shelves
Having heartburn after eating certain foods can be frustrating and painful. With over the counter medicine like fast-acting Zantac, digesting those certain foods can be less of a problem. How many times have you heard these lines? But you have never heard the lines of the potential warnings of taking Zantac.
Read MoreRound-Up® Costing Bayer Billions
Bayer-Global is very well known for all of the different types of products they have to aid in farming crop protection as well as consumer health. From nasal decongestant to common herbicides, many individuals come in contact with Bayer’s products every single day. There is one very large problem with one of their most popular products. One problem that will be costing them billions of dollars in financial settlements to the victims of non-Hodgkin’s lymphoma, a form of lymphatic cancer. The settlement amount has an allocated $10.05, and $10.85 billion dollars in funds.
Read MoreAre Our Cellphones Doing More Harm Than Good?
Americans are becoming addicted to their mobile devices. In turn, we’re seeing more people suffering from injuries due to their constant use of their phones, tablets, and even computers.
Read MoreVaping in Dallas County: Multiple Cases of Severe Pulmonary Disease
The use of e-cigarettes has long been skyrocketing among the youth of the United States. For the last five years, it has been incredibly noticeable. It’s becoming more and more popular among younger crowds as e-cigarette manufacturers were initially marketing their products with sweet or fruity type flavors.
Read MoreSeptember is Ovarian Cancer Awareness Month
Many have heard of the famous Johnson and Johnson marketing slogan of “No more tears” and assumed it had been a message conveyed to no more crying. However, Johnson and Johnson have brought a lot of tears to consumers over the past three decades.
Read MoreTRUVADA® Lawsuit
What is TRUVADA®?
TRUVADA®, created by the manufacturer Gilead, is a prescribed medication that was a combination of two different HIV medications, emtricitabine and tenofovir. It was used to treat the disease and to help reduce the risk of contracting HIV-1.
Read MoreRoundup™ Lawsuit Verdict Costs Bayer $2 Billion
Roundup™ Weedkiller is Killing Bayer
Monday’s jury verdict was the third strike against Bayer since their 2018 acquisition of Monsanto, the makers of the cancer-causing Roundup™ weedkiller.
$2.055 billion was awarded to a California couple who blame Roundup™ for the cause of their cancer. This verdict was the largest sum that Bayer has faced to-date in relation to the backlash from their Roundup™ product.
Read MoreGM’s Faulty Ignition Switch Case Reveals Troubling Behavior By Vehicle Manufacturer
As you may know from recent news reports, General Motors is currently involved in extensive litigation over 13 deaths that plaintiffs argue were caused by a faulty ignition switch on their GM manufactured vehicles. The allegedly defective switches were manufactured for GM by Delphi Automotive and have been used in an estimated 2.6 million cars which are now subject to recall to replace the defective switches. Of the defective vehicles, about 30,000 are currently being repaired, with the others scheduled for repairs down the line, as a judge recently declined to issue a “park it now” warning which would have taken all 2.6 million cars off the road immediately.
Xarelto® Litigation Update – Johnson & Johnson and Bayer Settle for $775 Million
MARCH 25, 2019 – Bayer and Johnson & Johnson have agreed to settle roughly 25,000 lawsuits that resulted from their blood thinner medicine, Xarelto®. Both companies will pay a sum of $775 million, split evenly between the two companies.
Both companies deny liability, and still stand behind their product albeit thousands of patients suffering from irreversible internal bleeding. Instead, they have decided to settle because of the extensive time and resources devoted to litigation.